Premium Nahrungsergänzungsmittel | artgerecht

Bronchoconstriction: Causes, Symptoms & Treatment

Bronchoconstriction is the narrowing of the airways caused by contraction of the smooth muscle in the bronchial walls. It commonly occurs in asthma and allergic reactions, making breathing difficult.

Regular tips about health Regular tips about health

Things worth knowing about "Bronchoconstriction"

Bronchoconstriction is the narrowing of the airways caused by contraction of the smooth muscle in the bronchial walls. It commonly occurs in asthma and allergic reactions, making breathing difficult.

What is Bronchoconstriction?

Bronchoconstriction refers to the narrowing of the bronchi – the airways leading into the lungs – caused by the contraction of smooth muscle in the bronchial walls. This narrowing increases airway resistance and restricts airflow, making it harder to breathe. Common signs include a whistling or wheezing sound during breathing, shortness of breath, and a feeling of tightness in the chest.

Causes

Bronchoconstriction can be triggered by a wide range of factors, broadly categorized as intrinsic (internal) or extrinsic (external):

Allergens: Pollen, dust mites, pet dander, and mold can trigger allergic bronchoconstriction in sensitive individuals.
Respiratory infections: Viral or bacterial infections cause airway inflammation that irritates the bronchial smooth muscle.
Cold and dry air: Inhaling cold air can provoke a reflex narrowing of the airways.
Exercise: Exercise-induced bronchoconstriction is particularly common during physical activity, especially in cold environments.
Chemical irritants: Cigarette smoke, air pollutants, and chemical fumes are frequent triggers.
Medications: Certain drugs such as non-selective beta-blockers or aspirin can induce bronchoconstriction in susceptible individuals.
Emotional stress: Psychological stress can influence bronchial muscle tone through the autonomic nervous system.

Physiological Mechanism

The smooth muscle of the bronchi is regulated by the autonomic nervous system. The parasympathetic nervous system promotes bronchoconstriction through the neurotransmitter acetylcholine acting on M3 muscarinic receptors. Conversely, the sympathetic nervous system causes bronchodilation via beta-2 adrenoreceptors. In allergic and inflammatory conditions, mediators such as histamine, leukotrienes, and prostaglandins play a central role in triggering and sustaining bronchoconstriction.

Symptoms

The severity of symptoms can vary considerably depending on the underlying cause and the degree of airway narrowing:

Wheezing or whistling sounds during breathing
Shortness of breath and dyspnea
Chest tightness or pressure
Dry, paroxysmal cough
Prolonged expiration phase
In severe cases: cyanosis (bluish discoloration of the lips) and difficulty speaking

Diagnosis

Diagnosis is typically established through a combination of medical history, physical examination, and pulmonary function testing:

Spirometry: Measures lung volumes and airflow rates; a reversible reduction in FEV1 (forced expiratory volume in one second) is characteristic of bronchoconstriction.
Peak flow measurement: A simple bedside test used for monitoring, especially in asthma management.
Bronchoprovocation test: Controlled inhalation of a trigger substance (e.g., methacholine) to confirm bronchial hyperresponsiveness.
Imaging: Chest X-ray or CT scan to rule out other underlying conditions.
Allergy testing: Skin prick tests or specific IgE blood tests to identify allergic triggers.

Treatment

Treatment depends on the underlying cause and the severity of the condition:

Pharmacological Treatment

Short-acting beta-2 agonists (SABA): Drugs such as salbutamol (albuterol) or fenoterol rapidly relax bronchial smooth muscle and are used for acute symptom relief.
Anticholinergics: Ipratropium bromide blocks the parasympathetic effect on bronchial smooth muscle, providing bronchodilation.
Inhaled corticosteroids (ICS): These reduce chronic airway inflammation and are a cornerstone of long-term asthma management.
Long-acting beta-2 agonists (LABA): Formoterol and salmeterol are used as maintenance therapy in combination with ICS.
Leukotriene receptor antagonists: Montelukast blocks inflammatory mediators and is particularly useful in allergic asthma.

Non-Pharmacological Measures

Avoidance of known triggers (allergen avoidance)
Respiratory physiotherapy and breathing exercises
Smoking cessation
Allergen immunotherapy (desensitization) for allergic causes

References

Global Initiative for Asthma (GINA) – Global Strategy for Asthma Management and Prevention (2023). Available at: https://ginasthma.org
Loscalzo J, Fauci A, Kasper D et al. – Harrison's Principles of Internal Medicine, 21st Edition, McGraw-Hill Education, 2022.
Barnes PJ – Pathophysiology of allergic inflammation. Immunological Reviews, 242(1):31-50, 2011. PubMed PMID: 21062319.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.